CompoAtlas

Ecorce de Magnolia

Food supplement declared in France, declaration No 2024-6-124, decision dated 4 June 2024

Ecorce de Magnolia (Elixlabs) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
Elixlabs
Food business operator placing the product on the market
SAMAGIT TECHNOLOGIE BIO-CHEM
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Capsule
Daily dose
660 mg
Directions for use
voie orale
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
Flavourings
Aucun

Declaration 325938, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Magnolia officinalis Rehder & E.H.WilsonEcorceAutre extrait sec660 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Elixlabs

List recorded in 2024. Photograph the packaging to check whether it has changed.